Istanbul Okan University
Tuzla, Istanbul, 34843, Turkey (Türkiye)
NCT Number: NCT07468487
This study aimed to evaluate the effectiveness of an educational program conducted by nurses on Human Papilloma Virus and its effects on women's health in women of reproductive age. Data were collected from women aged 30-49 with active sexual lives using a Descriptive Information Form and the HPV Knowledge Scale, and then analyzed and interpreted.
Looking for future studies?
Notify Me18 year–49 year
Female
Interventional
Not applicable
Tuzla, Istanbul, 34843, Turkey (Türkiye)
This study used randomized experimental and control groups in its design. Participants were women with active sexual lives who visited a Family Health Center in Istanbul for three months. Sample size was determined using power analysis. Women in the experimental group participated in a nursing education program titled "HPV and its Effects on Women's Health." Written informed consent was obtained from the participants. A pre-test was administered to all participants. Following the baseline assessment, participants in the experimental group participated in a nurse-led education program prepared by the researcher. The program focused on HPV transmission, prevention methods, vaccination, screening, and its effects on women's health. Participants in the control group did not receive any educational intervention at this stage. One month after the completion of the training, post-tests were administered to both groups. The assessment tools used were as follows: Women's sociodemographic characteristics, participation in health screenings, and HPV-related characteristics were recorded on an Information Form. Women's knowledge level about HPV was measured using the HPV Knowledge Scale. The scale consisted of 33 items and 2 sub-dimensions. The first sub-dimension of the scale is scored between 0 and 16. Higher scores indicate a higher level of general knowledge about HPV. The second subdimension measures the level of knowledge about the HPV vaccination program. The total score obtainable from this subdimension ranges from 0 to 6. Higher scores indicate a higher level of knowledge about HPV vaccination.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Sampling Inclusion Criteria:
Female individuals Having been diagnosed with HIV Being between 18-49 years of age Being sexually active
Sampling Exclusion Criteria:
Reproductive health education program prepared using Pender's Health Promotion Model.
Time frame: Up to 6 months
The Reproductive Health Protective Attitudes Scale for Married Women is a Likert-type scale consisting of 39 items, scored from 1 to 5. The total raw score obtained by summing the 39 items ranges from 39 to 195. It has five sub-dimensions. Higher total and sub-dimension scores indicate more positive attitudes and behaviors towards protecting women's reproductive health.
Okan University
Other
Evaluation of the Effectiveness of a Nursing Education Program on "HPV and Its Effects on Women's Health" Applied to Women of Reproductive Age
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07620197
Acquired Immunodeficiency Syndrome, Blood-Borne Infections
Kisumu, Kenya
View Trial DetailsNCT05933824
Acquired Immunodeficiency Syndrome, Blood-Borne Infections
Zhengzhou, Henan, China
View Trial DetailsNCT07423364
Acquired Immunodeficiency Syndrome, Blood-Borne Infections
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT07088770
Acquired Immunodeficiency Syndrome, Blood-Borne Infections
Kingston, New York, United States
View Trial Details